190 related articles for article (PubMed ID: 8423527)
1. Regio- and stereoselective propranolol metabolism by 15 forms of purified cytochromes P-450 from rat liver.
Fujita S; Umeda S; Funae Y; Imaoka S; Abe H; Ishida R; Adachi T; Masuda M; Kazusaka A; Suzuki T
J Pharmacol Exp Ther; 1993 Jan; 264(1):226-33. PubMed ID: 8423527
[TBL] [Abstract][Full Text] [Related]
2. Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes.
Masubuchi Y; Kagimoto N; Narimatsu S; Fujita S; Suzuki T
Drug Metab Dispos; 1993; 21(6):1012-6. PubMed ID: 7905378
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
Nakamura A; Yamamoto Y; Tasaki T; Sugimoto C; Masuda M; Kazusaka A; Fujita S
Drug Metab Dispos; 1995 Nov; 23(11):1268-73. PubMed ID: 8591729
[TBL] [Abstract][Full Text] [Related]
4. Regio- and stereoselectivity in propranolol metabolism by dog liver microsomes and the expressed dog CYP2D15.
Tasaki T; Iwata H; Kazusaka A; Fujita S
J Biochem; 1998 Apr; 123(4):747-51. PubMed ID: 9538270
[TBL] [Abstract][Full Text] [Related]
5. Propranolol oxidation by human liver microsomes--the use of cumene hydroperoxide to probe isoenzyme specificity and regio- and stereoselectivity.
Otton SV; Gillam EM; Lennard MS; Tucker GT; Woods HF
Br J Clin Pharmacol; 1990 Nov; 30(5):751-60. PubMed ID: 2271375
[TBL] [Abstract][Full Text] [Related]
6. Substrate stereoselectivity and enantiomer/enantiomer interaction in propranolol metabolism in rat liver microsomes.
Masubuchi Y; Yamamoto LA; Uesaka M; Fujita S; Narimatsu S; Suzuki T
Biochem Pharmacol; 1993 Nov; 46(10):1759-65. PubMed ID: 8250961
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P4502D isozymes catalyze the 4-hydroxylation of methamphetamine enantiomers.
Lin LY; Kumagai Y; Hiratsuka A; Narimatsu S; Suzuki T; Funae Y; Distefano EW; Cho AK
Drug Metab Dispos; 1995 Jun; 23(6):610-4. PubMed ID: 7587941
[TBL] [Abstract][Full Text] [Related]
8. Oxidation of (R)- and (S)-propranolol in human and dog liver microsomes. Species differences in stereoselectivity.
von Bahr C; Hermansson J; Lind M
J Pharmacol Exp Ther; 1982 Aug; 222(2):458-62. PubMed ID: 7097564
[TBL] [Abstract][Full Text] [Related]
9. Erythromycin as a specific substrate for cytochrome P4503A isozymes and identification of a high-affinity erythromycin N-demethylase in adult female rats.
Zhang XJ; Thomas PE
Drug Metab Dispos; 1996 Jan; 24(1):23-7. PubMed ID: 8825186
[TBL] [Abstract][Full Text] [Related]
10. Improved separation and immunodetection of rat cytochrome P450 4A forms in liver and kidney.
Okita JR; Johnson SB; Castle PJ; Dezellem SC; Okita RT
Drug Metab Dispos; 1997 Aug; 25(8):1008-12. PubMed ID: 9280410
[TBL] [Abstract][Full Text] [Related]
11. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
Kasahara M; Suzuki H; Komiya I
Drug Metab Dispos; 2000 Apr; 28(4):409-17. PubMed ID: 10725309
[TBL] [Abstract][Full Text] [Related]
12. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
Amato G; Longo V; Mazzaccaro A; Gervasi PG
Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925
[TBL] [Abstract][Full Text] [Related]
13. CYP2D-related metabolism in animals of the Canoidea superfamily - species differences.
Ishizuka M; Lee JJ; Masuda M; Akahori F; Kazusaka A; Fujita S
Vet Res Commun; 2006 Jul; 30(5):505-12. PubMed ID: 16755362
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of microsomal cytochrome P-450s.
Guengerich FP; Dannan GA; Wright ST; Martin MV; Kaminsky LS
Xenobiotica; 1982 Nov; 12(11):701-16. PubMed ID: 6762773
[TBL] [Abstract][Full Text] [Related]
15. Human cytochromes P-450.
Boobis AR; Davies DS
Xenobiotica; 1984; 14(1-2):151-85. PubMed ID: 6372265
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of cerivastatin by human liver microsomes in vitro. Characterization of primary metabolic pathways and of cytochrome P450 isozymes involved.
Boberg M; Angerbauer R; Fey P; Kanhai WK; Karl W; Kern A; Ploschke J; Radtke M
Drug Metab Dispos; 1997 Mar; 25(3):321-31. PubMed ID: 9172950
[TBL] [Abstract][Full Text] [Related]
17. Identification of CYP4A11 as the major lauric acid omega-hydroxylase in human liver microsomes.
Powell PK; Wolf I; Lasker JM
Arch Biochem Biophys; 1996 Nov; 335(1):219-26. PubMed ID: 8914854
[TBL] [Abstract][Full Text] [Related]
18. P-450-dependent metabolism of lauric acid in alcoholic liver disease: comparison between rat liver and kidney microsomes.
Amet Y; Lucas D; Zhang-Gouillon ZQ; French SW
Alcohol Clin Exp Res; 1998 Apr; 22(2):455-62. PubMed ID: 9581653
[TBL] [Abstract][Full Text] [Related]
19. Activation of propranolol and irreversible binding to rat liver microsomes: strain differences and effects of inhibitors.
Masubuchi Y; Narimatsu S; Suzuki T
Biochem Pharmacol; 1992 Feb; 43(3):635-7. PubMed ID: 1540217
[TBL] [Abstract][Full Text] [Related]
20. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate.
Masubuchi Y; Igarashi S; Suzuki T; Horie T; Narimatsu S
J Pharmacol Exp Ther; 1996 Nov; 279(2):724-31. PubMed ID: 8930177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
